Operating revenues, growth data, profitability and the behavior of our products.
Wed, 26/07/2017 - 12:28
0 minOperating revenues, growth data, profitability and the behavior of our products.
Related
Today, Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has announced the conclusion of the PRISMA-3 and BORIS studies, thus...
5 min
05/07/2019
The López-Belmonte family, the principal shareholders of Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”), have increased their interest in...
1 min
27/05/2019
2017 First Half Financial Results.png